1. Home
  2. SLDB vs CCO Comparison

SLDB vs CCO Comparison

Compare SLDB & CCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$9.55

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.41

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDB
CCO
Founded
2013
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
SLDB
CCO
Price
$9.55
$2.41
Analyst Decision
Strong Buy
Hold
Analyst Count
11
5
Target Price
$16.36
$2.12
AVG Volume (30 Days)
2.6M
6.5M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
34.97
110.81
EPS
N/A
N/A
Revenue
$8,094,000.00
$1,604,140,000.00
Revenue This Year
N/A
$5.35
Revenue Next Year
N/A
$4.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.57
52 Week Low
$3.79
$1.00
52 Week High
$11.45
$2.43

Technical Indicators

Market Signals
Indicator
SLDB
CCO
Relative Strength Index (RSI) 54.10 50.08
Support Level $6.38 $2.37
Resistance Level $11.45 $2.41
Average True Range (ATR) 0.68 0.02
MACD -0.12 -0.00
Stochastic Oscillator 32.02 25.00

Price Performance

Historical Comparison
SLDB
CCO

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

Share on Social Networks: